Interv Akut Kardiol. 2014;13(4):171

Novinky v přednemocniční péči u pacientů s AKS

Marek Janka
Koronární jednotka, Oblastní nemocnice Kladno

 

Keywords:  

Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janka M. Novinky v přednemocniční péči u pacientů s AKS. Interv Akut Kardiol. 2014;13(4):171.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. WIVIOTT, Stephen D, et al. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 2007-11-15, vol. 357, issue 20, s. 2001-2015. DOI: 10.1056/NEJMoa0706482.Dostupné z: http://www.nejm.org/doi/abs/10.1056/NEJMoa0706482. Go to original source... Go to PubMed...
    2. WALLENTIN, Lars et al. Ticagrelor versus Clo pidogrel in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 2009-09-10, vol. 361, issue 11, s. 1045-1057. DOI: 10.1056/NEJMoa0904327.Dostupné z: http://www.nejm.org/doi/abs/10.1056/NEJMoa0904327. Go to original source... Go to PubMed...
    3. MONTALESCOT, Gilles et al. A Comparison of prasugrel at the time of percutaneous Coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: Design and rationale for the ACCOAST study. American Heart Journal. 2011, vol. 161, issue 4, 650-656.e1. DOI: 10.1016/j.ahj.2010.10.017. Dostupné z: http://linkinghub.elsevier.com/retrieve/pii/S0002870310009 178. Go to original source... Go to PubMed...
    4. MONTALESCOT, Gilles et al. Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study. American Heart Journal. 2013, vol. 165, issue 4, s. 515-522. DOI: 10.1016/j.ahj.2012.12.015. Dostupné z: http://linkinghub.elsevier.com/retrieve/pii/S0002870313000525. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.